Plasma insulin levels in coronary artery disease. 1995

S V Kuruttukulam, and S Krishnaswami, and S T Chandy, and T R Muralidharan
Department of Cardiology, Christian Medical College Hospital, Vellore.

Seventy two consecutive patients without a history of diabetes and normal fasting plasma glucose were included in this study of insulin levels. Standard oral glucose tolerance test with 75 gm glucose and fasting and two hour insulin levels were estimated in all patients. Coronary artery disease (CAD) was confirmed or excluded by selective coronary arteriography. In 20 patients, CAD was diagnosed by electrocardiographic (ECG) and clinical evidence of earlier myocardial infarction. Mean fasting plasma insulin was 31.40 +/- 22.2 IU/dl in the CAD positive and 32.3 +/- 13.6 IU/dl in the CAD negative group. The mean two hour plasma insulin was 274.6 +/- 301.1 IU/dl in the CAD positive and 104.8 +/- 74.9 IU/dl in the CAD negative group (p < 0.04). Two hour plasma insulin levels were significantly higher in patients with atherosclerotic coronary artery disease. It is concluded that the estimation of a two hour plasma insulin level after 75 gm of glucose load, could help differentiate CAD from normals.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

S V Kuruttukulam, and S Krishnaswami, and S T Chandy, and T R Muralidharan
December 1963, Lancet (London, England),
S V Kuruttukulam, and S Krishnaswami, and S T Chandy, and T R Muralidharan
April 2007, Journal of thrombosis and haemostasis : JTH,
S V Kuruttukulam, and S Krishnaswami, and S T Chandy, and T R Muralidharan
January 2009, Thrombosis and haemostasis,
S V Kuruttukulam, and S Krishnaswami, and S T Chandy, and T R Muralidharan
March 2000, Indian journal of medical sciences,
S V Kuruttukulam, and S Krishnaswami, and S T Chandy, and T R Muralidharan
December 1994, Israel journal of medical sciences,
S V Kuruttukulam, and S Krishnaswami, and S T Chandy, and T R Muralidharan
January 2012, Revista brasileira de hematologia e hemoterapia,
S V Kuruttukulam, and S Krishnaswami, and S T Chandy, and T R Muralidharan
January 2012, Revista brasileira de hematologia e hemoterapia,
S V Kuruttukulam, and S Krishnaswami, and S T Chandy, and T R Muralidharan
January 1994, Atherosclerosis,
S V Kuruttukulam, and S Krishnaswami, and S T Chandy, and T R Muralidharan
April 2002, Anales de medicina interna (Madrid, Spain : 1984),
S V Kuruttukulam, and S Krishnaswami, and S T Chandy, and T R Muralidharan
October 2017, Medicine,
Copied contents to your clipboard!